financetom
Business
financetom
/
Business
/
Government extends air fare cap till February 24
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Government extends air fare cap till February 24
Oct 30, 2020 5:45 AM

The government has extended the fare cap on air tickets till February 24. The decision has been taken in light of the less than expected growth in air travel.

The government will assess the travel situation to decide whether the fare cap should be extended beyond February 24 later.

Watch video for more

(Edited by : Abhishek Jha)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
S&P lowers Nissan's outlook to negative, affirms BB+ ratings
S&P lowers Nissan's outlook to negative, affirms BB+ ratings
Jan 14, 2025
TOKYO (Reuters) - S&P Global Ratings revised Nissan Motor's ( NSANF ) credit outlook to negative from stable and affirmed its BB+ rating, as it expected it would take the Japanese automaker longer to improve its business performance. The negative outlook reflects our view that the company's creditworthiness will continue to deteriorate if profitability does not improve and positive free...
BP warns of fourth quarter profit hit as production and refining margins fall
BP warns of fourth quarter profit hit as production and refining margins fall
Jan 14, 2025
Jan 14 (Reuters) - BP warned on Tuesday that lower production, weak refining margins and sluggish trading would see its profit in the fourth quarter of 2024 fall from the previous three months. Since taking the helm a year ago, CEO Murray Auchincloss has scaled back the firm's energy transition strategy in an effort to boost profits and regain investor...
Biogen, Eisai Say Biologics License Application for Leqembi Accepted by US FDA
Biogen, Eisai Say Biologics License Application for Leqembi Accepted by US FDA
Jan 14, 2025
03:48 AM EST, 01/14/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said late Monday the US Food and Drug Administration has accepted Eisai's biologics license application for lecanemab-irmb subcutaneous autoinjector for weekly maintenance dosing in the treatment of patients with early Alzheimer's disease. The drug, known commercially as Leqembi, is indicated specifically for the treatment of Alzheimer's in patients with...
BurTech Acquisition, Blaize Complete Business Combination
BurTech Acquisition, Blaize Complete Business Combination
Jan 14, 2025
03:52 AM EST, 01/14/2025 (MT Newswires) -- BurTech Acquisition ( BRKH ) and Blaize said late Monday they have completed their business combination and formed a new entity called Blaize Holdings. The companies said the combined entity will begin trading on Nasdaq under the ticker symbols BZAI and BZAIW starting Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved